concentration in three cases of canine HS and evaluated its change over the course of the treatment.
This study included three dogs with HS that were treated at the Kitasato University Veterinary Teaching Hospital
Small Animal Medical Center （KVHSC） between August 2011 and July 2013. All dog owners provided written informed consent for participation in this study, which was approved by the Kitasato University Small Animal Committee. Blood samples （2 ml） from each dog were collected by jugular or cephalic venipuncture and held at room temperature for 30 min to allow the sample to coagulate before centrifugation for 5 min at 1,640 × g to separate the serum. Serum samples were stored at -20℃ until further testing. Serum ferritin concentrations were measured by a sandwich enzyme-linked immunosorbent assay （ELISA） using a method described previously ［2］ . Serum alanine aminotransferase （ALT） activity was measured by an auto analyzer （AU400; Beckman Coulter, Brea, CA, U.S.A.） , and the serum C-reactive protein （CRP） concentration was measured using a nephelometric immunoassay performed with a canine CRP detection kit （Arrows, Osaka, Japan） . Disease relapses were defined and characterized according to the new Response Evaluation Criteria in Solid Tumors （RECIST） guidelines and confirmed progressive disease; briefly, disease relapse was defined as a 20％ or greater increase in the sum of the longest diameters of a lesion or the appearance of a new metastatic lesion ［15］ .
Histological diagnosis was performed according to the histopathological criteria defined by the World Health Organization ［13］ and confirmed by immunohistochemistry using anti-CD204 （Trans Genic Inc., Kumamoto, Japan） and Iba-1 （Wako, Osaka, Japan） antibodies.
Case 1
A 9-year-old castrated male Flat-coated Retriever presenting with left hindlimb lameness of a few days' duration was diagnosed with hip dysplasia, which was followed up by the referring veterinarian 
